By Dr. A. Tom Horvath

The field of addiction has to get it together. This modest proposal offers five places to start, from individualizing treatment to professionalizing treaters. MORE  

By Maia Szalavitz

When Hazelden realized traditional treatment for young opiate-painkiller addicts was failing, it introduced maintenance therapy. Only a week later, the backlash has begun. MORE  

By Sacha Z. Scoblic

Medical intervention can dramatically increase recovery success rates. But without an attitude adjustment in the rooms and most rehabs, new and better drugs will remain elusive. MORE  

By Jennifer Matesa

The pharma giant says its decision is due to concerns over child safety—not a desire to promote its more profitable Suboxone films. MORE  

By Maia Szalavitz

When an addict gets pregnant, doctors advise her to do methadone, not go cold turkey. But to child welfare officials, the woman is still a junkie—and a danger to her newborn.  MORE  

By Maia Szalavitz

Just like ex-junkie Russell Brand, I used to believe that “maintenance” was as bad—if not worse—than active addiction. Here’s how I came to understand how fatally wrong I was. MORE  

By Maia Szalavitz

Combining buprenorphine with naltrexone produces highly promising results in a rat study. MORE  

By Maia Szalavitz

People with autism embraced the idea of "neurodiversity" to celebrate their condition as a positive identity, not a disease and disability. Should addicts do the same? MORE  

By Maia Szalavitz

If addiction is a medical disease, why have we abandoned it to untrained counselors, unproven treatments and unaccountable programs? MORE  

By Maia Szalavitz

Abuse of meds by American teens has reached epidemic proportions. But if we're serious about keeping kids away from Oxy and Adderall, we need to get honest with them. MORE